We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Amneal Pharmaceuticals and AvKARE have entered into a definitive agreement under which Amneal will acquire a 65.1% majority interest in AvKARE and its related affiliate doing business ...
Amneal Pharmaceuticals has agreed to buy a 65.1% stake in pharmaceuticals manufacturer and wholesaler AvKARE and its affiliate R&S Northeast for approximately $340m.